TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
MicroPort CardioFlow Medtech Corp. ( (HK:2160) ) has shared an announcement.
MicroPort CardioFlow Medtech Corp. has announced an extraordinary general meeting to discuss a proposed merger with MicroPort Cardiac Rhythm Management Limited. The merger involves issuing new shares to the target company’s shareholders, which could significantly impact the company’s market position and shareholder value.
The most recent analyst rating on (HK:2160) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on MicroPort CardioFlow Medtech Corp. stock, see the HK:2160 Stock Forecast page.
More about MicroPort CardioFlow Medtech Corp.
MicroPort CardioFlow Medtech Corp. is a company incorporated in the Cayman Islands, focusing on the medical technology industry. It specializes in the development and manufacturing of cardiovascular devices, aiming to provide innovative solutions for cardiac rhythm management.
Average Trading Volume: 7,409,061
Technical Sentiment Signal: Sell
Current Market Cap: HK$2.63B
See more data about 2160 stock on TipRanks’ Stock Analysis page.